Heterogeneity of airway hyperresponsiveness
1997; Wiley; Volume: 27; Issue: 6 Linguagem: Inglês
10.1111/j.1365-2222.1997.tb01187.x
ISSN1365-2222
AutoresS. D. Crowther, I. D. Chapman, John E. Morley,
Tópico(s)Respiratory and Cough-Related Research
ResumoClinical & Experimental AllergyVolume 27, Issue 6 p. 606-616 Heterogeneity of airway hyperresponsiveness S. D. CROWTHER, Corresponding Author S. D. CROWTHER Department of Respiratory Medicine, King's College Hospital, London, UKS. D. Crowther, Department of Respiratory Medicine, King's College Hospital, Denmark Hill, London SE5 9RS, UK.Search for more papers by this authorI. D. CHAPMAN, I. D. CHAPMAN Quintiles Scotland Ltd, Heriot Watt University, Edinburgh, London, UKSearch for more papers by this authorJ. MORLEY, J. MORLEY Department of Applied Pharmacology, National Heart and Lung Institute, London, UKSearch for more papers by this author S. D. CROWTHER, Corresponding Author S. D. CROWTHER Department of Respiratory Medicine, King's College Hospital, London, UKS. D. Crowther, Department of Respiratory Medicine, King's College Hospital, Denmark Hill, London SE5 9RS, UK.Search for more papers by this authorI. D. CHAPMAN, I. D. CHAPMAN Quintiles Scotland Ltd, Heriot Watt University, Edinburgh, London, UKSearch for more papers by this authorJ. MORLEY, J. MORLEY Department of Applied Pharmacology, National Heart and Lung Institute, London, UKSearch for more papers by this author First published: 27 April 2006 https://doi.org/10.1111/j.1365-2222.1997.tb01187.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Reproducibility and comparison of response to inhaled histamine and methacholine. Thorax 1978; 33: 705–10. 10.1136/thx.33.6.705 CASPubMedWeb of Science®Google Scholar 2 Dunnill MS, Masserella GA, Anderson J. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 1969; 24: 176–9. 10.1136/thx.24.2.176 CASPubMedWeb of Science®Google Scholar 3 Daniels EE. Control of airway smooth muscle. In: MA Kaliner, PJ Barnes, eds. The Airways: Neural control in Health and Disease. New York : Marcel Dekker. 1988. Google Scholar 4 Woolcock AJ, Salome CM, Yan K. The shape of the dose- response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 1984; 130: 71–5. CASPubMedGoogle Scholar 5 Barnes PJ. Asthma as an axon reflex. Lancet 1986; i: 242–5. 10.1016/S0140-6736(86)90777-4 Google Scholar 6 Moreno RH, Hogg JC, Paré PD. Mechanics of airway narrowing. Am Rev Respir Dis 1986; 133: 1171–80. CASPubMedWeb of Science®Google Scholar 7 Hogg JC. Pathology of asthma. J Allergy Clin Immunol 1993; 92: 1–5. 10.1016/0091-6749(93)90029-F PubMedWeb of Science®Google Scholar 8 National Heart, Lung, and Blood Institute, National Institute of Health. – International Consensus Report on Diagnosis and Management of Asthma. Eur Respir J 1992; 5: 601–41. PubMedGoogle Scholar 9 Arm JP, O'Hickey SP, Hawksworth RJ et al. Asthmatic airways have a disproportionate hyperresponsivenss to LTE4, as compared with normal airways, but not to LTC4, LTD4, methacholine, and histamine. Am Rev Respir Dis 1990; 142: 1112–8. 10.1164/ajrccm/142.5.1112 PubMedWeb of Science®Google Scholar 10 Adelroth E, Morris MM, Hargreave FE, O'Byrne PM. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. N Engl J Med 1986; 315: 480–4. 10.1056/NEJM198608213150803 CASGoogle Scholar 11 Chung KF, Dent G, Barnes PJ. Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leukocyte responses induced by platelet activating factor in man. Thorax 1989; 44: 102–7. 10.1136/thx.44.2.102 PubMedWeb of Science®Google Scholar 12 Chung KF, Barnes PJ. Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects. Thorax 1989; 44: 108–15. 10.1136/thx.44.2.108 PubMedWeb of Science®Google Scholar 13 Hoshiko K, Morley J. Exacerbation of airway hyperreactivity by racemic salbutamol in sensitized guinea-pigs. Jpn J Pharmacol 1993; 63: 159–63. 10.1254/jjp.63.159 CASPubMedWeb of Science®Google Scholar 14 Morley J. Anomalous effects of albuterol and other sympathomimetics in the guinea-pig. Clin Rev Allergy Immunol, in press. Google Scholar 15 O'Connor BJ, Aikman SL, Barnes PJ. Tolerance to th nonbronchodlator effects of inhaled β2-agonists in asthma. N Engl J Med 1992; 327: 1204–8. 10.1056/NEJM199210223271704 CASPubMedWeb of Science®Google Scholar 16 Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993; 342: 833–7. 10.1016/0140-6736(93)92695-P CASPubMedWeb of Science®Google Scholar 17 Thomson NC, Roberts R, Bandouvakis J, Newball H, Hargreave FE. Comparison of bronchial responses to prostaglandin F2α and methacholine. J Allergy Clin Immunol 1981; 68: 392–8. Google Scholar 18 Eggleston PA. A comparison of the asthmatic responses to methacholine and exercise. J Allergy Clin Immunol 1979; 63: 104–10. 10.1016/0091-6749(79)90199-4 PubMedWeb of Science®Google Scholar 19 Anderton RC, Cuff MT, Frith PA, Cockcroft DW, Morse JLC, Jones NL, Hargreave FE. Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol 1979; 63: 315–20. 10.1016/0091-6749(79)90125-8 PubMedWeb of Science®Google Scholar 20 Boulet LP, Legris C, Thibault L, Turcotte H. Comparative bronchial responses to hyperosmolar saline and methacholine in asthma. Thorax 1987; 42: 953–8. 10.1136/thx.42.12.953 CASPubMedWeb of Science®Google Scholar 21 De Vries K. Reactivity of the bronchial tree to different stimuli. Les Bronches 1968; 18: 439–542. PubMedGoogle Scholar 22 Pauwels R, Joos G, Van Der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not asthma. Clinical Allergy 1988; 18: 317–21. 10.1111/j.1365-2222.1988.tb02878.x PubMedWeb of Science®Google Scholar 23 Josephs LK, Gregg I, Holgate ST. Does non-specific bronchial responsiveness indicate the severity of asthma Eur Respir J 1990; 3: 220–7. CASPubMedWeb of Science®Google Scholar 24 Morley J, Chapman ID, Hoshiko K, Mazzoni L. Acute airway hyperreactivity in the guinea-pig. Eur Respir Rev 1995; 5: 202–10. Google Scholar 25 Sumitomo M, Nishikawa M, Fukuda T, Kaneko T, Ikeda H, Suziki S, Okubo T. Effects of ozone exposure on experimental asthma in guinea pigs sensitised with ovalbumin through the airway. Int Arch Allergy Appl Immunol 1990; 93: 139–47. 10.1159/000235293 CASPubMedWeb of Science®Google Scholar 26 Yeadon M, Wilkinson D, Darley-Usmar V, O'Leary VJ, Payne AN. Mechanisms contributing to ozone-induced bronchial hyperreactivity in guinea-pigs. Pulm Pharmacol 1992; 5: 39–50. 10.1016/0952-0600(92)90016-A CASPubMedWeb of Science®Google Scholar 27 Sterk PJ, Bel EH. Bronchial hyperresponsiveness: The need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J 1989; 2: 261–314. Google Scholar 28 Hoshiko K, Morley J. Allergic bronchospasm and airway hyperreactivity in the guinea-pig. Jpn J Pharmacol 1993; 63: 151–7. 10.1254/jjp.63.151 CASPubMedWeb of Science®Google Scholar 29 Chapman ID, Hoshiko K, Mazzoni L, Morley J. Characteristics of airway hyperreactivity following intravenous infusion of endotoxin in the guinea-pig. Br J Pharmacol 1993; 108: 210P. Google Scholar 30 Mazzoni L, Morley J, Page CP, Sanjar S. Induction of hyperreactivity by platelet-activating factor in the guinea- pig. J Physiol 1985; 365: 107P. Web of Science®Google Scholar 31 Sanjar S, Kristersson A, Mazzoni L, Morley J, Schaeublin E. Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline. J Physiol 1990; 425: 43–54. 10.1113/jphysiol.1990.sp018091 CASPubMedWeb of Science®Google Scholar 32 Ney UM. Propranolol-induced airway hyperreactivity in guinea-pigs. Br J Pharmacol 1983; 79: 1003–9. 10.1111/j.1476-5381.1983.tb10548.x CASPubMedWeb of Science®Google Scholar 33 Santing RE, Pasman Y, Olymulder CG, Roffel AF, Meurs H, Zaagsma J. Contribution of a cholinergic reflex mechanism to allergen-induced bronchial hyperreactivity in permenantly instrumented, unrestrained guinea-pigs. Br J Pharmacol 1995; 114: 414–8. 10.1111/j.1476-5381.1995.tb13242.x CASPubMedWeb of Science®Google Scholar 34 Mazzoni L, Naef R, Chapman ID, Morley J. Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of β2-selective sympathomimetics. Pulm Pharmacol 1994; 7: 367–76. 10.1006/pulp.1994.1043 CASPubMedWeb of Science®Google Scholar 35 Ishida K, Kelly LJ, Thomson RJ, Beattie LL, Schellenberg RR. Repeated antigen challenge induces airway hyperresponsiveness with tissue eosinophilia in guinea pigs. J Appl Physiol 1989; 67: 1133–9. 10.1152/jappl.1989.67.3.1133 CASPubMedWeb of Science®Google Scholar 36 Wang Z-L, Bramley AM, McNamara A, Paré PD, Bai TR. Chronic fenoterol exposure increases in vivo and in vitro airway responses in guinea pigs. Am J Respir Crit Care Med 1994; 149: 960–5. 10.1164/ajrccm.149.4.8143062 PubMedWeb of Science®Google Scholar 37 Buchheit KH, Hofmann A, Fozard JR. Salbutamol-induced airway hyperreactivity in guinea-pigs is not due to receptor desensitisation. Eur J Pharmacol, in press. Google Scholar 38 Mazzoni L, Chapman ID, Morley J. Changes in airway sensitivity to histamine are not necessarily paralleled by changed sensitivity to acetylcholine. Agents Actions Suppl 1991; 34: 257–66. CASPubMedWeb of Science®Google Scholar 39 Sanjar S, Smith D, Kristersson A, Morley J. Incubation of platelets with platelet-activating factor produces a factor which causes airway hyperreactivity in guinea-pigs. Br J Pharmacol 1989; 96: 75P. Google Scholar 40 Rylander R, Beijer L. Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. Am Rev Respir Dis 1987; 135: 83–6. CASPubMedWeb of Science®Google Scholar 41 Walle UK, Pesola GR, Walle T. Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. Br J Clin Pharmacol 1993; 35: 413–8. 10.1111/j.1365-2125.1993.tb04159.x CASPubMedWeb of Science®Google Scholar 42 Boulton DW, Fawcett JP. Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br J Pharmacol 1996; 41: 35–40. 10.1111/j.1365-2125.1996.tb00156.x CASPubMedWeb of Science®Google Scholar 43 Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM. Definition and antagonism of histamine H2-receptors. Nature. 1972; 236: 385–90. 10.1038/236385a0 CASPubMedWeb of Science®Google Scholar 44 Bray MA, Dumonde DC, Hanson JM, Morley J, Wolstencroft RA, Smart JV. Heterogeneity of guinea-pig lymphokines revealed by parallel bioassay. Clin Exp Immunol 1976; 23: 333–46. Web of Science®Google Scholar 45 Spector SL, Farr RS. A comparison of methacholine and histamine in asthmatics. J Allergy Clin Immunol 1975; 56: 308–16. 10.1016/0091-6749(75)90105-0 PubMedWeb of Science®Google Scholar 46 Fuller RW, Dixon CMS, Dollery CT, Barnes PJ. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis 1988; 133: 252–4. Web of Science®Google Scholar 47 Malo J-L, Cartier A, Pineau L, Gagnon G, Martin RR. Slope of the dose-response curve to inhaled histamine and methacholine and PC20 in subjects with symptoms of airway hyperexcitability and in normal subjects. Am Rev Respir Dis 1985; 132: 644–7. CASPubMedWeb of Science®Google Scholar 48 Wiebicke W, Jörres R, Magnussen H. Comparison of the effects of inhaled corticosteroids on the airway response to histamine, methacholine, hyperventilation, and sulphur dioxide in subjects with asthma. J Allergy Clin Immunol 1990; 86: 915–23. 10.1016/S0091-6749(05)80155-1 PubMedWeb of Science®Google Scholar 49 Makino S. Clinical significance of bronchial sensitivity to acetylcholine and histamine in bronchial asthma. J Allergy 1966; 38: 127–42. 10.1016/0021-8707(66)90036-0 PubMedWeb of Science®Google Scholar 50 Calhoun WJ, Swenson CA, Dick EC, Schwartz LB, Lemanske RF, Busse WW. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1991; 144: 1267–73. 10.1164/ajrccm/144.6.1267 PubMedGoogle Scholar 51 Molfino NA, Slutsky AS, Hoffstein V, McClean PA, Rebuck AS, Drazen JM, Zamel N. Changes in cross- sectional airway areas induced by methacholine, histamine and LTC4 in asthmatic subjects. Am Rev Respir Dis 1992; 146: 577–80. 10.1164/ajrccm/146.3.577 CASPubMedWeb of Science®Google Scholar 52 Chatham M, Bleecker ER, Smith PL, Rosenthal RR, Mason P, Norman PS. A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects. Am Rev Respir Dis 1982; 126: 235–240. CASPubMedWeb of Science®Google Scholar 53 O'Hickey SP, Hawksworth RJ, Fong CY, Arm JP, Spur BW, Lee TH. Leukotrienes C4, D4, and E4 enhance histamine responsiveness in asthmatic airways. Am Rev Respir Dis 1991; 144: 1053–7. 10.1164/ajrccm/144.5.1053 PubMedWeb of Science®Google Scholar 54 Pichurko BM, Ingram RH Jr, Sperling RI, Lafleur JE, Corey EJ, Austen KF, Drazen JM. Localization of the site of the bronchoconstrictor effects of leukotriene C4 compared with that of histamine in asthmatic subjects. Am Rev Respir Dis 1989; 140: 334–9. 10.1164/ajrccm/140.2.334 PubMedWeb of Science®Google Scholar 55 Hardy CC, Bradding P, Robinson C, Holgate ST. The combined effect of two pairs of mediators, adenosine with methacholine and prostaglandin D2 with histamine, on airway calibre in asthma. Clin Sci 1986; 71: 385–92. 10.1042/cs0710385 CASPubMedWeb of Science®Google Scholar 56 Polosa R, Holgate ST. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am Rev Respir Dis 1990; 142: 1367–71. 10.1164/ajrccm/142.6_Pt_1.1367 CASPubMedWeb of Science®Google Scholar 57 O'Connor BJ, Ridge SM, Barnes PJ, Fuller RW. Greater effect of inhaled budesonide on adenosine 5′-monophosphate-induced than on sodium-metabisulphite-induced bronchoconstriction in asthma. Am Rev Respir Dis 1992; 146: 560–4. 10.1164/ajrccm/146.3.560 PubMedWeb of Science®Google Scholar 58 Haugaard L, Iversen M, Dahl R. A comparative study of four different bronchial challenge tests. Allergy 1992; 47: 138–42. 10.1111/j.1398-9995.1992.tb00954.x PubMedWeb of Science®Google Scholar 59 Phillips GD, Holgate ST. Interaction of inhaled LTC4 with histmine and PGD2 on airway calibre in asthma. J Applied Physiol 1989; 66: 304–12. PubMedWeb of Science®Google Scholar 60 Roisman G, Lacronique JG, Desmazes-Dufeu N, Carré C, Le Cae A, Dusser DJ. Airway responsiveness to bradykinin is related to eosinophilic inflammation in asthma. Am J Respir Crit Care Med 1996; 153: 381–90. 10.1164/ajrccm.153.1.8542147 PubMedWeb of Science®Google Scholar 61 Thomson NC, Roberts R, Bandouvakis J, Newball H, Hargreave FE. Comparison of bronchial response to prostaglandin F2α and methacholine. J Allergy Clin Immunol 1981; 68: 392–98. Google Scholar 62 Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806–7. 10.1164/ajrccm/139.3.806 CASPubMedWeb of Science®Google Scholar 63 Wardlow AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988; 137: 62–9. 10.1164/ajrccm/137.1.62 PubMedWeb of Science®Google Scholar 64 Mathé AA, Hedquist P, Holmgren A, Svanborg N. Bronchial hyperreactivity to prostaglandin F2α and histamine in patients with asthma. Br Med J 1973; i: 193–6. 10.1136/bmj.1.5847.193 Google Scholar 65 Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 1983; 15: 161–5. 10.1111/j.1365-2125.1983.tb01481.x CASPubMedWeb of Science®Google Scholar 66 Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 1977; 7: 503–13. 10.1111/j.1365-2222.1977.tb01481.x CASPubMedWeb of Science®Google Scholar 67 Freitag A, Watson RM, Matsos G, Eastwood C, O'Byrne PM. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. Thorax 1993; 48: 594–8. 10.1136/thx.48.6.594 CASPubMedWeb of Science®Google Scholar 68 Aalbers R, Kauffman HF, Köeter GH, Postma DS, De Vries K, De Monchy JGR. Dissimilarity in methacholine and adenosine 5-monophosphate responsiveness 3 and 24h after allergen challenge. Am Rev Respir Dis 1991; 144: 352–7. 10.1164/ajrccm/144.2.352 CASPubMedWeb of Science®Google Scholar 69 Foresi A, Mattoli S, Corbo GM, Verga A Sommaruga A, Ciappi G. Late bronchial response and increase in methacholine hyperresponsiveness after exercise and distilled water challenge in atopic subjects with asthma with dual asthmatic response to allergen inhalation. J Allergy Clin Immunol 1986; 78: 1130–9. 10.1016/0091-6749(86)90262-9 PubMedWeb of Science®Google Scholar 70 Cartier A, Thomson NC, Frith PA, Roberts R, Tech M, Hargreave FE. Allergen-induced increase in bronchial responsiveness to histamine relationship to the late asthmatic response and change in airway calibre. J Allergy Clin Immunol 1982; 70: 170–77. 10.1016/0091-6749(82)90038-0 PubMedWeb of Science®Google Scholar 71 Cockcroft DW, Murdock KY. Changes in bronchial responsiveness to histamine at intervals after antigen challenge. Thorax 1987; 42: 302–8. 10.1136/thx.42.4.302 PubMedWeb of Science®Google Scholar 72 Djukanovic R, Polosa R, Holgate ST. Effect of bronchial challenge on airway responsiveness to methacholine and bradykinin. Thorax 1991; 46: 748P. Google Scholar 73 Gibson PG, Manning PJ, O'Byrne PM, Girgis-Gabardo A, Dolovich J, Denburgh JA, Hargreave FE. Allergen-induced asthmatic responses. Relationship between increases in circulating eosinophils, basophils and their progenitors. Am Rev Respir Dis 1991; 143: 331–5. 10.1164/ajrccm/143.2.331 PubMedWeb of Science®Google Scholar 74 Durham SR, Craddock CF, Cookson WO, Benson MK. Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses. J Allergy Clin Immunol 1988; 82: 764–70. 10.1016/0091-6749(88)90077-2 PubMedWeb of Science®Google Scholar 75 Djukanovic R. Is airways hyperreactivity selective or non- selective? In: TT Hansel, J. Morleyeds. New drugs in allergy and asthma. Basel : Birkhauser Verlag, 1993: 231–9. 10.1007/978-3-0348-7324-6_20 Web of Science®Google Scholar 76 Sears MR, Taylor DR, Print CG, Lake DC, Qingqing L, Flannery EM, Yates DM, Lucas MK, Herbison GP. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–6. 10.1016/0140-6736(90)93098-A CASPubMedWeb of Science®Google Scholar 77 Spitzer WO, Suissa S, Ernst P et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501–6. 10.1056/NEJM199202203260801 CASPubMedWeb of Science®Google Scholar 78 Perrin-Fayolle M. Salbutamol in the treatment of asthma. Lancet 1995; 346: 1101. 10.1016/S0140-6736(95)91775-6 CASPubMedWeb of Science®Google Scholar 79 American Thoracic Society. Definitions and classification of chronic bronchitis, asthma and pulmonary emphysema and related conditions. Am Rev Respir Dis 1962; 85 762–8. Google Scholar 80 Josephs LK, Gregg I, Mullee MA, Holgate ST. Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma. Am Rev Respir Dis 1989; 140: 350–7. 10.1164/ajrccm/140.2.350 CASPubMedWeb of Science®Google Scholar 81 Peat JK, Salome CM, Bauman A, Toelle BG, Wachinger SL, Woolcock AJ. Repeatability of histamine bronchial challenge and comparability with methacholine bronchial challenge in a population of Australian schoolchildren. Am Rev Respir Dis 1991; 144: 336–43. 10.1164/ajrccm/144.2.338 Google Scholar 82 Sterk PJ. The determinants of the severity of acute airway narrowing in asthma and COPD. Respir Med 1992; 86: 391–6. 10.1016/S0954-6111(06)80005-3 CASPubMedWeb of Science®Google Scholar 83 Chapman ID, Kristersson A, Mathelin G, Schaeublin E, Mazzoni L, Boubekeur K, Murphy N, Morley J. Effects of a potassium channel opener (SDZ PCO 400) on guinea-pig and human pulmonary airways. Br J Pharmacol 1992; 106: 423–9. 10.1111/j.1476-5381.1992.tb14350.x CASPubMedWeb of Science®Google Scholar 84 Morley J. Immunopharmacology of asthma. Trends Pharmacol Sci 1993; 14: 208–13. 10.1016/0165-6147(93)90210-B PubMedWeb of Science®Google Scholar 85 Zimmerman B, Feanny S, Reisman J et al. Allergy in asthma. I. The dose relationship of allergy to severity of childhood asthma. J Allergy Clin Immunol 1988; 81: 63–70. 10.1016/0091-6749(88)90221-7 PubMedWeb of Science®Google Scholar 86 Intrinsic asthma M. Schmitz-Schumann, G. Menz, U Gostabel, CP. Pageeds. Basel : Birkhauser Verlag, 1989. Google Scholar 87 Chan-Yeung M, Lam S. Occupational asthma. Am Rev Respir Dis 1986; 133: 786–803. Google Scholar 88 Mapp CE, Chiesura-Corona P, De Marzo N, Fabbri LM. Persistant asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI). Am Rev Respir Dis 1988; 137: 1326–9. 10.1164/ajrccm/137.6.1326 PubMedWeb of Science®Google Scholar 89 Hunt LW, Gleich GJ, Ohnishi T et al. Endotoxin contamination causes neutrophilia following pulmonary allergen challenge. Am J Respir Crit Care Med 1994; 149: 1471–75. 10.1164/ajrccm.149.6.8004300 PubMedWeb of Science®Google Scholar 90 Magnussen H, Nowak D. Spontaneous changes of airway hyperresponsiveness in bronchial asthma. Eur Respir J 1988; 1: 480–1. PubMedWeb of Science®Google Scholar 91 Ind PW, Dixon CMS, Fuller RW, Barnes PJ. Anticholinergic blockade of beta-blocker-induced bronchoconstriction. Am Rev Respir Dis 1989; 139: 1390–4. 10.1164/ajrccm/139.6.1390 CASPubMedWeb of Science®Google Scholar 92 Finnerty JP, Holgate ST. The contribution of histamine release and vagal reflexes, alone and in combination, to exercise-induced asthma. Eur Respir J 1993; 6: 1132–7. PubMedWeb of Science®Google Scholar 93 Souza LM, Silverman M. Prostaglandins in exercise- induced asthma. Clin Allergy 1981; 11: 506–7. 10.1111/j.1365-2222.1981.tb01627.x CASPubMedWeb of Science®Google Scholar 94 Chapman ID, Foster A, Morley J. The relationship between inflammation and hyperreactivity of the airways in asthma. Clin Exp Allergy 1993; 23: 168–71. 10.1111/j.1365-2222.1993.tb00877.x PubMedWeb of Science®Google Scholar 95 Cuts E, Levisohn H, Cooper DM. Ultrastructure of airways in children with asthma. Histopathology 1978; 2: 407–21. 10.1111/j.1365-2559.1978.tb01735.x PubMedWeb of Science®Google Scholar 96 Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; i: 520–4. 10.1016/S0140-6736(89)90067-6 Google Scholar 97 Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989; i: 1346–48. 10.1016/S0140-6736(89)92801-8 Google Scholar 98 Gibson PG, Mattoli S, Sears MR, Dolovich J, Hargreave FE. Increased peak flow variability in children with asymptomatic hyperresponsiveness. Eur Respir J 1995; 8: 1731–5. 10.1183/09031936.95.08101731 PubMedWeb of Science®Google Scholar 99 Tattersfleld AE. Effect of beta-agonists and anticholinergic drugs on bronchial reactivity. Am Rev Respir Dis 1987; 136 [suppl.]: 64–68. 10.1164/ajrccm/136.4_Pt_2.S64 Google Scholar 100 Bel EH, Zwinderman AH, Timmers MC, Dijkman JH, Sterk PJ. The protective effect of a beta2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive disease. Thorax 1991; 46: 9–14. 10.1136/thx.46.1.9 CASPubMedWeb of Science®Google Scholar 101 Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel- group controlled trial. J Allergy Clin Immunol 1992; 90: 32–42. 10.1016/S0091-6749(06)80008-4 Google Scholar 102 Cockcroft DW, Swystun VA, Bhagat R. Interaction of inhaled β2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med, in press. Google Scholar 103 Hoshiko K, Kristersson A, Morley J. Ketotifen inhibits exacerbation of allergic airway hyperreactivity by racemic salbutamol in the guinea pig. J Allergy Clin Immunol 1993; 91: 909–16. 10.1016/0091-6749(93)90349-K PubMedWeb of Science®Google Scholar Citing Literature Volume27, Issue6June 1997Pages 606-616 ReferencesRelatedInformation
Referência(s)